Terms: = Liver cancer AND MYC, c-Myc, 4609, ENSG00000136997 AND Treatment
441 results:
1. liver cancer development driven by the AP-1/c-Jun~Fra-2 dimer through c-myc.
Bakiri L; Hasenfuss SC; Guío-Carrión A; Thomsen MK; Hasselblatt P; Wagner EF
Proc Natl Acad Sci U S A; 2024 Apr; 121(18):e2404188121. PubMed ID: 38657045
[TBL] [Abstract] [Full Text] [Related]
2. Inhibition of PTPRE suppresses tumor progression and improves sorafenib response in hepatocellular carcinoma.
Dong R; Wang T; Dong W; Zhu H; Liu Q; Liang H; Chen X; Zhang B; Zhang X
Biomed Pharmacother; 2024 Apr; 173():116366. PubMed ID: 38458013
[TBL] [Abstract] [Full Text] [Related]
3. LAPTM4B-mediated hepatocellular carcinoma stem cell proliferation and MDSC migration: implications for HCC progression and sensitivity to PD-L1 monoclonal antibody therapy.
Wang H; Zhou Q; Xie DF; Xu Q; Yang T; Wang W
Cell Death Dis; 2024 Feb; 15(2):165. PubMed ID: 38388484
[TBL] [Abstract] [Full Text] [Related]
4. Hepatitis B surface antigen positivity is associated with poor short- and long-term outcomes in patients with diffuse large B-cell lymphoma who received CHOP or R-CHOP.
Zhan Z; Guo W; Wan X; Wang B; Li J; Wang H; Li Z; Huang Y; Young KH; Bai O
Front Immunol; 2024; 15():1324113. PubMed ID: 38318173
[TBL] [Abstract] [Full Text] [Related]
5. FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-myc in colorectal cancer.
Li H; Zheng N; Guo A; Tang W; Li M; Cao Y; Ma X; Cao H; Ma Y; Wang H; Zhao S
Cell Death Dis; 2024 Feb; 15(2):107. PubMed ID: 38302412
[TBL] [Abstract] [Full Text] [Related]
6. Unraveling the Role of RNA-Binding Proteins, with a Focus on RPS5, in the Malignant Progression of Hepatocellular Carcinoma.
Zhou C; Wu Q; Zhao H; Xie R; He X; Gu H
Int J Mol Sci; 2024 Jan; 25(2):. PubMed ID: 38255847
[TBL] [Abstract] [Full Text] [Related]
7. Integrative analysis of disulfidptosis and immune microenvironment in hepatocellular carcinoma: a putative model and immunotherapeutic strategies.
Yang T; Liu J; Liu F; Lei J; Chen S; Ma Z; Ke P; Yang Q; Wen J; He Y; Duan J; Zeng X
Front Immunol; 2023; 14():1294677. PubMed ID: 38235128
[TBL] [Abstract] [Full Text] [Related]
8. FGF19 and its analog Aldafermin cooperate with myc to induce aggressive hepatocarcinogenesis.
Ursic-Bedoya J; Desandré G; Chavey C; Marie P; Polizzi A; Rivière B; Guillou H; Assenat E; Hibner U; Gregoire D
EMBO Mol Med; 2024 Feb; 16(2):238-250. PubMed ID: 38228803
[TBL] [Abstract] [Full Text] [Related]
9. BLVRA exerts its biological effects to induce malignant properties of hepatocellular carcinoma cells via Wnt/β-catenin pathway.
Chen X; Yang F; Zhang C; Wang X; Yuan C; Shi D; Zhu S; Zhang X; Chen X; Zhao W
J Mol Histol; 2024 Apr; 55(2):159-167. PubMed ID: 38216836
[TBL] [Abstract] [Full Text] [Related]
10. Seven oxidative stress-related genes predict the prognosis of hepatocellular carcinoma.
Miao C; He X; Chen G; Kahlert UD; Yao C; Shi W; Su D; Hu L; Zhang Z
Aging (Albany NY); 2023 Dec; 15(24):15050-15063. PubMed ID: 38097352
[TBL] [Abstract] [Full Text] [Related]
11. The role and mechanism of HIF-1α-mediated glypican-3 secretion in hypoxia-induced tumor progression in hepatocellular carcinoma.
Wang P; Tong K; Li Y; Li X; Zhang Y; Gu J; Lei P; Yan S; Hu P
Cell Signal; 2024 Feb; 114():111007. PubMed ID: 38081444
[TBL] [Abstract] [Full Text] [Related]
12. FAT4 loss initiates hepatocarcinogenesis through the switching of canonical to noncanonical WNT signaling pathways.
Huang FY; Wong DK; Mak LY; Cheung TT; Zhang SS; Chau HT; Hui RW; Seto WK; Yuen MF
Hepatol Commun; 2023 Dec; 7(12):. PubMed ID: 38055646
[TBL] [Abstract] [Full Text] [Related]
13. LINC02561 promotes metastasis in HCC via HIF1-α/NDRG1/UPF1 axis.
Li SN; Li MX; Guo WW; Zhang LR; Ding YH; Wu XJ
Gene; 2024 Feb; 896():148033. PubMed ID: 38013127
[TBL] [Abstract] [Full Text] [Related]
14. The Molecular, Immunologic, and Clinicodemographic Landscape of myc-Amplified Advanced Prostate cancer.
Jin WH; Zhang L; Graf R; Raskina K; Tukachinsky H; Huang RSP; McGregor K; Alshalalfa M; Hougen HY; Khan A; Punnen S; Schrock AB; Venstrom J; Mahal BA
Clin Genitourin Cancer; 2024 Feb; 22(1):e163-e169.e1. PubMed ID: 37978032
[TBL] [Abstract] [Full Text] [Related]
15. Tumor cell-derived exosomes mediating hsa_circ_0001739/lncRNA AC159540.1 facilitate liver metastasis in colorectal cancer.
Yue CF; Chen JG; Li ZY; Li LS; Chen JR; Xie HX; Zhang B; Guo YM
Cell Biol Toxicol; 2023 Dec; 39(6):2551-2568. PubMed ID: 37957486
[TBL] [Abstract] [Full Text] [Related]
16. USP22-JMJD8 axis promotes Lenvatinib resistance in hepatocellular carcinoma.
Guo J; Zhao J
Biochim Biophys Acta Mol Cell Res; 2024 Jan; 1871(1):119617. PubMed ID: 37898375
[TBL] [Abstract] [Full Text] [Related]
17. Tumor Profiles of Late Presentation Uveal Ring Melanoma With Novel Characteristics - A Case Series.
Lim JZ; Crawford AZ; McGhee CNJ
Invest Ophthalmol Vis Sci; 2023 Oct; 64(13):44. PubMed ID: 37889509
[TBL] [Abstract] [Full Text] [Related]
18. HuR-induced circ_0082319 contributes to hepatocellular carcinoma by elevating PTK2 through miR-505-3p.
Qin C; Liu S; Chen W; Xue D; Guo T; Wu B
Naunyn Schmiedebergs Arch Pharmacol; 2024 May; 397(5):3111-3126. PubMed ID: 37878047
[TBL] [Abstract] [Full Text] [Related]
19. A combined bioinformatics and experimental approach identifies RMI2 as a Wnt/β-catenin signaling target gene related to hepatocellular carcinoma.
Tsai HW; Cheng SW; Chen CC; Chen IW; Ho CL
BMC Cancer; 2023 Oct; 23(1):1025. PubMed ID: 37875822
[TBL] [Abstract] [Full Text] [Related]
20. Dissection of action mechanisms of Zuogui Pill in the treatment of liver cancer based on machine learning and network pharmacology: A review.
Guang B; Gao X; Chen X; Li R; Ma L
Medicine (Baltimore); 2023 Oct; 102(42):e35628. PubMed ID: 37861529
[TBL] [Abstract] [Full Text] [Related]
[Next]
